Nuveen’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $87.4M | Sell |
534,750
-115,654
| -18% | -$17.8M | 0.02% | 434 |
|
|
2025
Q4 | $113M | Buy |
650,404
+62,282
| +11% | +$11.4M | 0.03% | 369 |
|
|
2025
Q3 | $84.7M | Sell |
588,122
-865
| -0.1% | -$106K | 0.02% | 445 |
|
|
2025
Q2 | $59.3M | Sell |
588,987
-569,107
| -49% | -$43.5M | 0.02% | 548 |
|
|
2025
Q1 | $88.4M | Sell |
1,158,094
-108,536
| -9% | -$8.3M | 0.03% | 430 |
|
|
2024
Q4 | $87.4M | Buy |
1,266,630
+205,473
| +19% | +$14.8M | 0.02% | 435 |
|
|
2024
Q3 | $77.5M | Sell |
1,061,157
-268,790
| -20% | -$19.8M | 0.02% | 490 |
|
|
2024
Q2 | $89.1M | Buy |
1,329,947
+792,716
| +148% | +$30.7M | 0.03% | 437 |
|
|
2024
Q1 | $14.6M | Buy |
537,231
+160,016
| +42% | +$4.48M | ﹤0.01% | 1368 |
|
|
2023
Q4 | $11.7M | Buy |
377,215
+28,449
| +8% | +$738K | ﹤0.01% | 1500 |
|
|
2023
Q3 | $8.81M | Sell |
348,766
-7,076
| -2% | -$162K | ﹤0.01% | 1559 |
|
|
2023
Q2 | $7.51M | Buy |
355,842
+1,931
| +0.5% | +$36.6K | ﹤0.01% | 1672 |
|
|
2023
Q1 | $6.04M | Sell |
353,911
-702,679
| -67% | -$13.7M | ﹤0.01% | 1781 |
|
|
2022
Q4 | $21.1M | Buy |
1,056,590
+232,374
| +28% | +$4.49M | 0.01% | 1004 |
|
|
2022
Q3 | $17.8M | Buy |
824,216
+342,694
| +71% | +$8.22M | 0.01% | 1099 |
|
|
2022
Q2 | $9.5M | Sell |
481,522
-23,549
| -5% | -$493K | ﹤0.01% | 1541 |
|
|
2022
Q1 | $11.7M | Buy |
505,071
+627
| +0.1% | +$14.6K | ﹤0.01% | 1547 |
|
|
2021
Q4 | $13.3M | Sell |
504,444
-30,630
| -6% | -$876K | ﹤0.01% | 1515 |
|
|
2021
Q3 | $14.3M | Sell |
535,074
-29,284
| -5% | -$768K | ﹤0.01% | 1519 |
|
|
2021
Q2 | $16.1M | Buy |
564,358
+2,571
| +0.5% | +$76.3K | ﹤0.01% | 1538 |
|
|
2021
Q1 | $19.1M | Sell |
561,787
-40,206
| -7% | -$1.54M | 0.01% | 1356 |
|
|
2020
Q4 | $20M | Buy |
601,993
+62,742
| +12% | +$2.29M | 0.01% | 1267 |
|
|
2020
Q3 | $17.3M | Sell |
539,251
-36,077
| -6% | -$1.04M | 0.01% | 1143 |
|
|
2020
Q2 | $15.8M | Buy |
575,328
+22,894
| +4% | +$543K | 0.01% | 1187 |
|
|
2020
Q1 | $8.86M | Sell |
552,434
-31,678
| -5% | -$751K | ﹤0.01% | 1365 |
|
|
2019
Q4 | $13.9M | Buy |
584,112
+114,232
| +24% | +$2.32M | 0.01% | 1384 |
|
|
2019
Q3 | $8.29M | Buy |
469,880
+69,837
| +17% | +$1.35M | ﹤0.01% | 1680 |
|
|
2019
Q2 | $10.2M | Buy |
+400,043
| New | +$11.1M | ﹤0.01% | 1597 |
|
|
2016
Q3 | – | Sell |
-43,148
| Closed | -$425K | – | 1421 |
|
|
2016
Q2 | $425K | Sell |
43,148
-9,557
| -18% | -$112K | ﹤0.01% | 1205 |
|
|
2016
Q1 | $668 | Sell |
52,705
-12,003
| -19% | -$158K | ﹤0.01% | 1161 |
|
|
2015
Q4 | $1.17K | Buy |
64,708
+8,617
| +15% | +$152K | 0.01% | 996 |
|
|
2015
Q3 | $1.04K | Buy |
+56,091
| New | +$1.4M | 0.01% | 1065 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Nuveen's INSM Position: Q1 2026 in Review
Nuveen reduced its Insmed (INSM) stake by 18% in Q1 2026, selling an estimated $17.8M and leaving 534,750 shares worth $87.4M. The position accounts for 0.02% of the portfolio, ranked #434.
Nuveen first reported a position in INSM in Q3 2015 and has held it in 32 quarters since. The position peaked at $113M in Q4 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Nuveen held 534,750 shares of Insmed worth $87.4M as of Q1 2026.
- Nuveen sold 115,654 Insmed shares in Q1 2026, an estimated $17.8M.
- Insmed made up 0.02% of Nuveen's portfolio in Q1 2026, its #434 holding.
- Nuveen first reported a position in Insmed in Q3 2015 and has held it in 32 quarters since.
- Nuveen's Insmed position peaked at $113M in Q4 2025.
- 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.